Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 12;8(1):169.
doi: 10.1038/s41597-021-00962-3.

The 2021 update of the EPA's adverse outcome pathway database

Affiliations

The 2021 update of the EPA's adverse outcome pathway database

Holly M Mortensen et al. Sci Data. .

Abstract

The EPA developed the Adverse Outcome Pathway Database (AOP-DB) to better characterize adverse outcomes of toxicological interest that are relevant to human health and the environment. Here we present the most recent version of the EPA Adverse Outcome Pathway Database (AOP-DB), version 2. AOP-DB v.2 introduces several substantial updates, which include automated data pulls from the AOP-Wiki 2.0, the integration of tissue-gene network data, and human AOP-gene data by population, semantic mapping and SPARQL endpoint creation, in addition to the presentation of the first publicly available AOP-DB web user interface. Potential users of the data may investigate specific molecular targets of an AOP, the relation of those gene/protein targets to other AOPs, cross-species, pathway, or disease-AOP relationships, or frequencies of AOP-related functional variants in particular populations, for example. Version updates described herein help inform new testable hypotheses about the etiology and mechanisms underlying adverse outcomes of environmental and toxicological concern.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
AOP-DB Data Structure. Green, Ovals indicate data tables in the AOP-DB SQL relational database; Blue, Diamonds indicate local, post-processing files necessary, where modified data are stored; Yellow, Rectangles indicate corresponding subroutines necessary to process source data; and Red, Diamonds indicate publicly available, third party source data included in AOP-DB v.2. Arrow edges indicate foreign key relationships.
Fig. 2
Fig. 2
AOP Tissue Network Visualization Tool illustrates the tissue-gene network built with user query for SREBF1 for hepatocyte tissue. Associated AOPs for SREBF1 are listed in the left-hand pane.
Fig. 3
Fig. 3
Minor allele frequency (MAF) distribution for SNPs associated with 104 functionally relevant Human AOP-genes for five 1000 Genomes Super populations: American (Blue); African (Yellow); East Asian (Red); European (Green); South Asian (Black).
Fig. 4
Fig. 4
AOP-DB search page illustrating “Basic Search” task bar with accepted user input types and download file specificity.
Fig. 5
Fig. 5
AOP-DB Semantic Mapping using the Resource Description Framework (RDF) illustrating Chemical-Gene Interaction, Protein-Protein Interaction, ToxCast Assay, and Pathway tables.

Dataset use reported in

  • doi: 10.1007/s00335-018-9738-7

References

    1. US Public Law 114–182. Frank R. Lautenberg Chemical Safety for the 21st Century Act (ed 114th Congress, 2016).
    1. Pittman ME, Edwards SW, Ives C, Mortensen HM. AOP-DB: A database resource for the exploration of Adverse Outcome Pathways through integrated association networks. Toxicol Appl Pharmacol. 2018;343:71–83. doi: 10.1016/j.taap.2018.02.006. - DOI - PMC - PubMed
    1. Mortensen HM, et al. Leveraging human genetic and adverse outcome pathway (AOP) data to inform susceptibility in human health risk assessment. Mamm Genome. 2018;29:190–204. doi: 10.1007/s00335-018-9738-7. - DOI - PMC - PubMed
    1. Patlewicz G, Worth AP, Ball N. Validation of Computational Methods. Adv Exp Med Biol. 2016;856:165–187. doi: 10.1007/978-3-319-33826-2_6. - DOI - PubMed
    1. Delrue N, et al. The adverse outcome pathway concept: A basis for developing regulatory decision-making tools. Altern Lab Anim. 2016;44:417–429. doi: 10.1177/026119291604400504. - DOI - PubMed